Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetone SCHEMBL8780130 | 1.00 | LMNA (0.40) | LMNAALDH1A1TDP1GAATRPA1 | |
| SCHEMBL2561638 | 0.97 | ALDH1A1 (0.33) | LMNAALDH1A1TDP1GAATRPA1 | |
| Acrylic Acid SCHEMBL29754165 | 0.81 | LMNA (0.50) | LMNAALDH1A1 | |
| SCHEMBL9248985 | 0.79 | ALDH1A1 (0.33) | ALDH1A1TDP1TRPA1 | |
| SCHEMBL16450972 | 0.75 | FDPS (0.35) | LMNAALDH1A1 | |
| SCHEMBL19734497 | 0.73 | CYP4F2 (0.31) | — | |
| Acetic Acid SCHEMBL9779003 | 0.71 | FFAR3 (0.44) | LMNAALDH1A1TDP1 | |
| Acetic Acid SCHEMBL8521559 | 0.71 | FFAR3 (0.44) | LMNAALDH1A1TDP1 | |
| SCHEMBL8074334 | 0.69 | ALDH1A1 (0.41) | LMNAALDH1A1TDP1GAATRPA1 | |
| Tribromoethanol SCHEMBL11210485 | 0.69 | LMNA (0.43) | LMNAALDH1A1TDP1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10301305-B2 | Heteroaromatic derivatives and their use as pharmaceuticals | MUTABILIS (FR) | 2019-05-28 | — | — | US | disclosed |
| EP-3110803-B1 | HETEROAROMATIC DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | MUTABILIS (FR) | 2018-07-11 | — | — | EP | disclosed |
| US-20170015661-A1 | HETEROAROMATIC DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | MUTABILIS (FR) | 2017-01-19 | — | — | US | disclosed |
| EP-3110803-A1 | HETEROAROMATIC DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | Mutabilis (FR) | 2017-01-04 | — | — | EP | disclosed |
| WO-2015128333-A1 | HETEROAROMATIC DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | LABORATOIRE BIODIM (FR) | 2015-09-03 | — | — | WO | disclosed |
| US-6384151-B1 | REACTING MALEIC ANHYDRIDE WITH WATER, REACTING REACTION MIXTURE WITH DICYCLOPENTADIENE, REACTING PRODUCT OBTAINED WITH POLYHYDRIC ALCOHOL, OR POLYHYDRIC ALCOHOL AND POLYBASIC ACID, TO OBTAIN DICYCLOPENTADIENE-MODIFIED UNSATURATED POLYESTER | NIPPON SHOKUBAI CO., LTD. (JP) | 2002-05-07 | — | — | US | disclosed |
| EP-1085032-A1 | DICYCLOPENTADIENE-MODIFIED UNSATURATED POLYESTER, PROCESS FOR PRODUCING THE SAME, AND RESIN AND MOLDING MATERIAL EACH CONTAINING UNSATURATED POLYESTER | Nippon Shokubai Co., Ltd. (JP) | 2001-03-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170015661-A1 | HETEROAROMATIC DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | MSR1, IFNAR1, NOD2 | LMNA 2216/4885ALDH1A1 2744/4885TDP1 4609/4885 |
| US-10301305-B2 | Heteroaromatic derivatives and their use as pharmaceuticals | MSR1, IFNAR1, NOD2 | LMNA 2216/4885ALDH1A1 2744/4885TDP1 4609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.